Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.400
+0.020 (1.45%)
At close: Nov 20, 2024, 4:00 PM
1.440
+0.040 (2.86%)
Pre-market: Nov 21, 2024, 7:29 AM EST
Intelligent Bio Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2017 |
| Operating Revenue | 3.19 | 3.11 | 1.26 | - | - | - | Upgrade
|
| Other Revenue | - | - | - | - | 1.98 | 0.19 | Upgrade
|
| Revenue | 3.19 | 3.11 | 1.26 | - | 1.98 | 0.19 | Upgrade
|
| Revenue Growth (YoY) | 55.29% | 147.58% | - | - | 949.30% | - | Upgrade
|
| Cost of Revenue | 1.65 | 1.69 | 0.93 | - | - | - | Upgrade
|
| Gross Profit | 1.54 | 1.43 | 0.33 | - | 1.98 | 0.19 | Upgrade
|
| Selling, General & Admin | 8.75 | 9.26 | 8.03 | 4.92 | 3.36 | 2.2 | Upgrade
|
| Research & Development | 2.52 | 1.67 | 0.51 | 3.85 | 3.84 | 0.59 | Upgrade
|
| Other Operating Expenses | -0.44 | -0.42 | -0.74 | -0.44 | - | - | Upgrade
|
| Operating Expenses | 12.02 | 11.71 | 8.76 | 8.34 | 7.19 | 2.79 | Upgrade
|
| Operating Income | -10.48 | -10.28 | -8.44 | -8.34 | -5.21 | -2.6 | Upgrade
|
| Interest Expense | -0.15 | -0.17 | -0.22 | -0.01 | -1.09 | -0.46 | Upgrade
|
| Interest & Investment Income | 0.14 | 0.08 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.14 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | -0 | -0.27 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.04 | 0.18 | 2.15 | - | -0.36 | -0.25 | Upgrade
|
| EBT Excluding Unusual Items | -10.45 | -10.19 | -6.51 | -8.33 | -7.06 | -3.19 | Upgrade
|
| Impairment of Goodwill | - | - | -4.16 | - | - | - | Upgrade
|
| Pretax Income | -10.45 | -10.19 | -10.66 | -8.33 | -7.06 | -3.19 | Upgrade
|
| Earnings From Continuing Operations | -10.45 | -10.19 | -10.66 | -8.33 | -7.06 | -3.19 | Upgrade
|
| Minority Interest in Earnings | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Net Income | -10.42 | -10.16 | -10.63 | -8.31 | -7.04 | -3.16 | Upgrade
|
| Net Income to Common | -10.42 | -10.16 | -10.63 | -8.31 | -7.04 | -3.16 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 2038.60% | 1802.54% | 37.01% | 40.81% | 22.38% | 1.52% | Upgrade
|
| EPS (Basic) | -4.17 | -6.38 | -127.00 | -135.93 | -162.17 | -89.22 | Upgrade
|
| EPS (Diluted) | -4.17 | -6.38 | -127.00 | -135.93 | -162.17 | -89.22 | Upgrade
|
| Free Cash Flow | -10.87 | -9.79 | -7.88 | -3.74 | -11.3 | -0.5 | Upgrade
|
| Free Cash Flow Per Share | -4.35 | -6.15 | -94.16 | -61.18 | -260.32 | -14.06 | Upgrade
|
| Gross Margin | 48.31% | 45.81% | 25.99% | - | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -328.80% | -330.46% | -671.23% | - | -263.28% | -1378.90% | Upgrade
|
| Profit Margin | -326.77% | -326.40% | -845.89% | - | -355.33% | -1676.23% | Upgrade
|
| Free Cash Flow Margin | -340.92% | -314.71% | -627.15% | - | -570.39% | -264.18% | Upgrade
|
| EBITDA | -9.51 | -9.31 | -7.62 | - | - | - | Upgrade
|
| EBITDA Margin | -298.42% | -299.15% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.97 | 0.97 | 0.81 | - | - | - | Upgrade
|
| EBIT | -10.48 | -10.28 | -8.44 | -8.34 | -5.21 | -2.6 | Upgrade
|
| EBIT Margin | - | - | - | - | -263.28% | - | Upgrade
|
| Revenue as Reported | - | - | - | - | 1.98 | 0.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.